Search research articles
Contact Us
Filters
Showing results (71-80 of 96) with videos related to
Page
of 10
Sort By:
JCO Oncology Practice
|
July 1, 2020
Management of Breast Cancer During the COVID-19 Pandemic: A Stage- and Subtype-Specific Approach
Jennifer Y Sheng, Cesar A Santa-Maria, Neha Mangini, et al.
Molecular Nutrition & Food Research
|
August 23, 2025
Dietary Blueberry Supplementation Attenuates the Effects of an Ultra-Processed Food Cafeteria Diet on Weight Gain and Metabolic Parameters, Enhancing Nutrigenomic Profiles in C57BL/6 Mice
Felipe Mateus Pellenz, Mayara Souza de Oliveira, Shiva Cerutti Witteé, et al.
Nature Communications
|
March 28, 2024
Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study
Filipa Lynce, Candace Mainor, Renee N Donahue, et al.
Nature Communications
|
May 10, 2024
Author Correction: Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study
Filipa Lynce, Candace Mainor, Renee N Donahue, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 18, 2023
Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study
Filipa Lynce, Candace Mainor, Renee N Donahue, et al.
Blood
|
November 8, 2021
COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA
Livio Pagano, Jon Salmanton-García, Francesco Marchesi, et al.
Ciencia & Saude Coletiva
|
June 11, 2020
Social distancing measures to control the COVID-19 pandemic: potential impacts and challenges in Brazil
Estela M L Aquino, Ismael Henrique Silveira, Julia Moreira Pescarini, et al.
Blood Advances
|
May 2, 2022
COVID-19 and hairy-cell leukemia: an EPICOVIDEHA survey
Sylvain Lamure, Jon Salmanton-García, Elena Robin-Marieton, et al.
Blood Advances
|
April 14, 2023
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post-CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey
Jaap A van Doesum, Jon Salmanton-García, Francesco Marchesi, et al.
Therapeutic Advances in Hematology
|
March 16, 2023
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry
Monia Marchetti, Jon Salmanton-García, Shaimaa El-Ashwah, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 96) with videos related to
Sort By:
Page
of 10
JCO Oncology Practice
|
July 1, 2020
Management of Breast Cancer During the COVID-19 Pandemic: A Stage- and Subtype-Specific Approach
Jennifer Y Sheng, Cesar A Santa-Maria, Neha Mangini, et al.
Molecular Nutrition & Food Research
|
August 23, 2025
Dietary Blueberry Supplementation Attenuates the Effects of an Ultra-Processed Food Cafeteria Diet on Weight Gain and Metabolic Parameters, Enhancing Nutrigenomic Profiles in C57BL/6 Mice
Felipe Mateus Pellenz, Mayara Souza de Oliveira, Shiva Cerutti Witteé, et al.
Nature Communications
|
March 28, 2024
Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study
Filipa Lynce, Candace Mainor, Renee N Donahue, et al.
Nature Communications
|
May 10, 2024
Author Correction: Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study
Filipa Lynce, Candace Mainor, Renee N Donahue, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 18, 2023
Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study
Filipa Lynce, Candace Mainor, Renee N Donahue, et al.
Blood
|
November 8, 2021
COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA
Livio Pagano, Jon Salmanton-García, Francesco Marchesi, et al.
Ciencia & Saude Coletiva
|
June 11, 2020
Social distancing measures to control the COVID-19 pandemic: potential impacts and challenges in Brazil
Estela M L Aquino, Ismael Henrique Silveira, Julia Moreira Pescarini, et al.
Blood Advances
|
May 2, 2022
COVID-19 and hairy-cell leukemia: an EPICOVIDEHA survey
Sylvain Lamure, Jon Salmanton-García, Elena Robin-Marieton, et al.
Blood Advances
|
April 14, 2023
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post-CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey
Jaap A van Doesum, Jon Salmanton-García, Francesco Marchesi, et al.
Therapeutic Advances in Hematology
|
March 16, 2023
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry
Monia Marchetti, Jon Salmanton-García, Shaimaa El-Ashwah, et al.
Page
of 10